Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Invested Capital (2022 - 2025)

Cannabis Bioscience International Holdings' Invested Capital history spans 4 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 20.38% year-over-year to -$1.3 million; the TTM value through Nov 2025 reached -$1.3 million, down 20.38%, while the annual FY2025 figure was -$1.1 million, 6.49% down from the prior year.
  • Invested Capital for Q4 2025 was -$1.3 million at Cannabis Bioscience International Holdings, down from -$1.2 million in the prior quarter.
  • Across five years, Invested Capital topped out at -$405301.0 in Q4 2022 and bottomed at -$1.3 million in Q4 2025.
  • The 4-year median for Invested Capital is -$1.0 million (2024), against an average of -$931495.6.
  • The largest annual shift saw Invested Capital tumbled 104.74% in 2023 before it fell 6.49% in 2025.
  • A 4-year view of Invested Capital shows it stood at -$405301.0 in 2022, then crashed by 104.74% to -$829807.0 in 2023, then plummeted by 35.0% to -$1.1 million in 2024, then decreased by 20.38% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Invested Capital are -$1.3 million (Q4 2025), -$1.2 million (Q3 2025), and -$1.1 million (Q2 2025).